Enliven: Challenges in Cancer Detection and Therapy | Open Access Journals | Open Access Articles


Samir A. Farghaly, MD, PhD

Joan and Sanford I. Weill Medical College/ The Graduate School of Medical Sciences , and The New York Presbyterian Hospital-Weill Cornell Medical Center, Cornell University, New York, NY-USA

Dear Colleagues

I am delighted to welcome you to the inaugural issue of Enliven: Challenges in Cancer Detection and Therapy Journal (ECCDTJ). The journal represents an established forum for all aspects of basic sciences, detection and management of cancer.

The journal publishes a broad range of original, peer-reviewed papers from scientific and clinical research to reviews/mini reviews relevant to practice, reports of major impact, case reports, editorials, books review, country cancer report, and letters to the editor/ replies. It also will include occasional supplements on clinical and basic sciences symposia related to cancer. In addition, the journal will publish proceedings of conferences on all aspects of cancer. We are encouraging manuscript submission from physicians and medical scientist from developing and developed countries. I'm confident that the Journal will be widely read by clinicians, scientists, and trainees in the field of cancer, and allied specialties. The journal will play a major role in education in cancer detection and therapy. The journal will have a global outreach, and will be indexed in major data bases. The journal will cover the following topics:

Cancer genetic pathways
Cell cycle control
Cancer and stem cells
Cancer therapeutics
Cancer drug discovery and applications
Cancer genomics and proteomics
Tumor immunology
Cancer epidemiology and etiology
Cancer and biostatistics
Cancer prevention
Cancer and pharmaceutics
Cancer pathology
Cancer Detection
Clinical cancer management
Cancer radiation studies
Cancer cell biology
Quality of life 0f patients with various cancer types

The journal will be published every 3 month for the first year, followed by monthly issuing afterwards. The journal is published in on-line format.

I'm pleased to note that we have several outstanding national/ international physicians and medical scientists who joined our editorial board as editors. They will contribute a great deal to the journal progress.

I strongly encourage you to submit your work for consideration for publication in the ECCDTJ. An enthusiastic submission requires an energetic and dedicated editorial board to ensure that your manuscript will be reviewed and published rapidly. The guidelines for submission are posted on the journal website: www.enlivenarchive.org/cancer.php

I truthfully hope that you will find this issue and future issues of interest, and that you will enjoy and benefit from reading the publication.

Samir A. Farghaly, M.D., PhD
Founder Editor-in- Chief
Enliven: Challenges in Cancer Detection and Therapy Journal
New York, NY- USA